Clinical and Life Sciences · 27 September 2026 to 27 September 2026 · 1 headlines · MedCity News
Mirum Pharma Pill Lands FDA Approval for Ultra-Rare Bone Growth Disorder
Mirum Pharmaceuticals has received FDA approval for a pill to treat an ultra-rare bone growth disorder.
As it ran
27 September 2026
More from US healthcare
- STAT Plus: Members of Congress push back on plan to create a commission of political appointees to review NIH grants 27 September 2026
- MedTech Commercialization Gap: Moving Beyond Technical Viability 27 September 2026
- FDA's gene therapy approval and accelerated drug review programs 26 September 2026
- FDA issues draft guidance on premarket submissions of robotically-assisted surgical devices 26 September 2026
- 2 Hot Dogs or 1 Large Cookie? A Study of Risks by Amount of Ultraprocessed Food 25 September 2026
- 3 Common Drugs Older Adults Might Be Overusing 25 September 2026
- Healthcare's most influential leaders 25 September 2026
- A breakthrough pancreatic cancer drug won approval. They still struggle to access it 25 September 2026